{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:47:58Z","timestamp":1788385678170,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["16H06527"],"award-info":[{"award-number":["16H06527"]}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AMED"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neures.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T17:18:04Z","timestamp":1522257484000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Therapeutic time window of anti-high mobility group box-1 antibody administration in mouse model of spinal cord injury"],"prefix":"10.1016","volume":"141","author":[{"given":"Masahide","family":"Nakajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Uezono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-7379","authenticated-orcid":false,"given":"Hidenori","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setsuro","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5901-9628","authenticated-orcid":false,"given":"Kinichi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2018.03.004_bib0005","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/neuros\/nyw080","article-title":"Traumatic Spinal Cord Injury-Repair and Regeneration","volume":"80","author":"Ahuja","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neures.2018.03.004_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00266-004-0022-8","article-title":"Estimation of breast prosthesis volume by the Cavalieri principle using magnetic resonance images","volume":"28","author":"Akbas","year":"2004","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.neures.2018.03.004_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neures.2018.03.004_bib0020","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","article-title":"Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94","volume":"20","author":"Asahi","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neures.2018.03.004_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/neu.2006.23.635","article-title":"Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains","volume":"23","author":"Basso","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neures.2018.03.004_bib0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neures.2018.03.004_bib0035","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/BRS.0b013e318203941c","article-title":"2011: high-Mobility group box-1 and its receptors contribute to proinfl ammatory response in the acute phase of spinal cord injury in rats","volume":"36","author":"Chen","year":"2011","journal-title":"Spine (Phila\u2009Pa 1976)"},{"key":"10.1016\/j.neures.2018.03.004_bib0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/nbm.1343","article-title":"Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI","volume":"22","author":"Cohen","year":"2009","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neures.2018.03.004_bib0045","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/stem.1083","article-title":"Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells","volume":"30","author":"Fujimoto","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.neures.2018.03.004_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2010.05728.x","article-title":"Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke","volume":"1207","author":"Hayakawa","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neures.2018.03.004_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neulet.2016.12.004","article-title":"Neuroprotection and secondary damage following spinal cord injury: concepts and methods","volume":"652","author":"Hilton","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2018.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/BRS.0b013e3181bd14b6","article-title":"High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis","volume":"35","author":"Kawabata","year":"2010","journal-title":"Spine (Phila\u2009Pa 1976)"},{"key":"10.1016\/j.neures.2018.03.004_bib0065","article-title":"High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation","author":"Kigerl","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neures.2018.03.004_bib0070","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.22023","article-title":"Protective role of aquaporin-4 water channels after contusion spinal cord injury","volume":"67","author":"Kimura","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2018.03.004_bib0075","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1089\/neu.2009.1150","article-title":"A systematic review of directly applied biologic therapies for acute spinal cord injury","volume":"28","author":"Kwon","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neures.2018.03.004_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/exnr.2000.7494","article-title":"Role of tumor necrosis factor-\u03b1 in neuronal and glial apoptosis after spinal cord injury","volume":"166","author":"Lee","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2018.03.004_bib0085","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/brain\/aws171","article-title":"Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury","volume":"135","author":"Lee","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neures.2018.03.004_bib0090","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.neures.2018.03.004_bib0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neures.2018.03.004_bib0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneumeth.2010.12.013","article-title":"Comparison evans blue injection routes: intravenous vs.Intraperitoneal: for measurement of blood-Brain barrier in a mice hemorrhage model","volume":"195","author":"Manaenko","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neures.2018.03.004_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/251204","article-title":"Neurotrauma and inflammation: CNS and PNS responses","volume":"2015","author":"Mietto","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.neures.2018.03.004_bib0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuroscience.2016.08.037","article-title":"Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury","volume":"335","author":"Morita","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neures.2018.03.004_bib0115","article-title":"iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury","volume":"1","author":"Nagoshi","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neures.2018.03.004_bib0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2014.05.021","article-title":"Global gene expression analysis following spinal cord injury in non-human primates","volume":"261","author":"Nishimura","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2018.03.004_bib0125","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1523\/JNEUROSCI.22-17-07526.2002","article-title":"Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events","volume":"22","author":"Noble","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2018.03.004_bib0130","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1172\/JCI90608","article-title":"Cell biology of spinal cord injury and repair","volume":"127","author":"O\u2019Shea","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neures.2018.03.004_bib0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.23602","article-title":"Anti-high mobility group box-1 antibody therapy for traumatic brain injury","volume":"72","author":"Okuma","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2018.03.004_bib0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.jcbfm.9600582","article-title":"Early release of HMGB-1 from neurons after the onset of brain ischemia","volume":"28","author":"Qiu","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neures.2018.03.004_bib0145","first-page":"e50062","article-title":"An in vivo assay to test blood vessel permeability","author":"Radu","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neures.2018.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S1474-4422(14)70144-9","article-title":"Restoring function after spinal cord injury: towards clinical translation of experimental strategies","volume":"13","author":"Ramer","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neures.2018.03.004_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmed.2012.11.007","article-title":"CNS sterile injury: just another wound healing?","volume":"19","author":"Shechter","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neures.2018.03.004_bib0160","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nm.2749","article-title":"Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain","volume":"18","author":"Shichita","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2018.03.004_bib0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00132","article-title":"Post-ischemic inflammation in the brain","volume":"3","author":"Shichita","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neures.2018.03.004_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pneurobio.2013.11.002","article-title":"From basics to clinical: a comprehensive review on spinal cord injury","volume":"114","author":"Silva","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neures.2018.03.004_bib0175","doi-asserted-by":"crossref","DOI":"10.1002\/stem.2802","article-title":"Prior treatment with anti-HMGB1 antibody boosts human neural stem cell transplantation-mediated functional recovery after spinal cord injury","author":"Uezono","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.neures.2018.03.004_bib0180","first-page":"1","article-title":"Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2018.03.004_bib0185","first-page":"1","article-title":"HMGB1\/Advanced Glycation End Products (RAGE) does not aggravate inflammation but promote endogenous neural stem cells differentiation in spinal cord injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2018.03.004_bib0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1503\/cmaj.121206","article-title":"Emerging therapies for acute traumatic spinal cord injury","volume":"185","author":"Wilson","year":"2013","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.neures.2018.03.004_bib0195","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stemcr.2015.06.004","article-title":"Engrafted neural stem\/progenitor cells promote functional recovery through synapse reorganization with spared host neurons after spinal cord injury","volume":"5","author":"Yokota","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neures.2018.03.004_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/08977150360547116","article-title":"Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats","volume":"20","author":"Yune","year":"2003","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neures.2018.03.004_bib0205","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","article-title":"Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke"}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010218301251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010218301251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:55:33Z","timestamp":1719921333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010218301251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":41,"alternative-id":["S0168010218301251"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2018.03.004","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic time window of anti-high mobility group box-1 antibody administration in mouse model of spinal cord injury","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}